Timepoint | Full analysis set | Switched patientsa | Treatment-naïve patients | |||
---|---|---|---|---|---|---|
n | Improved/stabilized/ worsened (%) | n | Improved/stabilized/ worsened (%) | n | Improved/stabilized/ worsened (%) | |
Dose-adjustment phase | ||||||
Week 2 | 293 | 8/90/2 | 82 | 5/94/1 | 211 | 9/89/3 |
Week 4 | 292 | 13/84/2 | 81 | 12/86/1 | 211 | 14/83/3 |
Week 6 | 289 | 15/83/2 | 79 | 11/87/1 | 210 | 16/82/2 |
Week 8 | 284 | 19/79/2 | 78 | 17/82/1 | 206 | 20/78/2 |
Maintenance phase | ||||||
Week 12 | 264 | 22/73/5 | 70 | 21/76/3 | 194 | 22/72/6 |
Week 24 | 208 | 25/70/5 | 52 | 17/79/4 | 156 | 28/67/5 |
Week 36 | 162 | 30/69/1 | 43 | 23/77/0 | 119 | 32/66/2 |
Week 48 | 114 | 29/69/2 | 28 | 21/79/0 | 86 | 31/66/2 |